Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Feb;44(1):e44-e45.
doi: 10.1111/ijlh.13699. Epub 2021 Sep 15.

Isolated erythrocytosis: A consequence of COVID-19 induced hypoxia

Ashish Maheshwari  1 , Guru Priya  1 , Meenu Bajpai  1
Affiliations
Comment

Isolated erythrocytosis: A consequence of COVID-19 induced hypoxia

Ashish Maheshwari et al. Int J Lab Hematol. 2022 Feb.
No abstract available

Keywords: COVID-19; erythrocytosis; haemoglobin.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests.

Comment on

References

    1. Ministry of Health and Family Welfare, Government of India . Drugs and Cosmetics Act 1940 and Rules 1945, Amended. https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf‐documents/actsru.... Accessed June 12, 2021.
    1. Fan BE, Chong VCL, Chan SSW, et al. Hematologic parameters in patients with COVID‐19 infection [published correction appears in Am J Hematol. 2020 Nov;95(11):1442]. Am J Hematol. 2020;95(6):E131‐E134. doi:10.1002/ajh.25774 - DOI - PubMed
    1. Djakpo DK, Wang Z, Zhang R, Chen X, Chen P, Antoine MMLK. Blood routine test in mild and common 2019 coronavirus (COVID‐19) patients. Bioscience Reports. 2020;40:(8):1‐5. 10.1042/bsr20200817 - DOI - PMC - PubMed
    1. Thomas T, Stefanoni D, Dzieciatkowska M, et al. Evidence of structural protein damage and membrane lipid remodelling in red blood cells from COVID‐19 patients. J Proteome Res. 2020;19(11):4455‐4469. doi:10.1021/acs.jproteome.0c00606 - DOI - PMC - PubMed
    1. Ehrenreich H, Weissenborn K, Begemann M, Busch M, Vieta E, Miskowiak KW. Erythropoietin as candidate for supportive treatment of severe COVID‐19. Molecular Medicine. 2020;26:(1):1‐9. 10.1186/s10020-020-00186-y - DOI - PMC - PubMed